Xeris Pharmaceuticals Inc (NASDAQ: XERS) — Healthcare · Share Price, Chart & Market Data
About: Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.14 (+1.41%)
XERSXeris Pharmaceuticals Inc
Loading watchlist status…
Trade XERS now
Xeris Pharmaceuticals Inc share price
XERS price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 3:43 pm GMT+0
XERS price performance
4.16%
5D
13.611%
1M
-16.531%
YTD
39.116%
1Y
XERS price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 3:43 pm GMT+0
XERS details
XERS Market Signals